Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net income	$ 12,798,260	$ 9,268,796
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	55,126	(254,643)
Realized investment gains, net	(975,769)	(37,470)
Change in fair value of equity securities	(16,290,482)	(12,376,263)
Unrealized trading losses included in income	0	7,301
Amortization of cost of insurance acquired	153,542	158,954
Provision for deferred income tax expenses	3,703,042	2,557,601
Depreciation and depletion	375,893	462,855
Stock-based compensation	13,974	299,314
Charges for mortality and administration of universal life and annuity products	(1,354,014)	(1,374,829)
Interest credited to account balances	872,357	901,542
Change in accrued investment income	184,152	280,803
Change in reinsurance receivables	277,737	99,789
Change in policy liabilities and accruals	(1,298,156)	(1,219,854)
Change in income taxes receivable	47,948	45,205
Change in other assets and liabilities, net	(1,818,821)	(835,179)
Net cash used in operating activities	(3,255,211)	(2,016,078)
Proceeds from investments sold and matured:
Fixed maturities available for sale	3,000,000	5,000,000
Equity securities	2,331,830	3,519,729
Trading securities	0	102,699
Mortgage loans	1,096,597	209,928
Notes receivable	95,403	421,847
Real estate	0	722,925
Policy loans	248,124	247,513
Short-term investments	0	15,750,000
Total proceeds from investments sold and matured	6,771,954	25,974,641
Cost of investments acquired:
Equity securities	(9,131,704)	(3,107,915)
Mortgage loans	(675,112)	(599,189)
Note receivable	(1,318,133)	(800,000)
Real estate	(465,800)	(545,180)
Policy loans	(202,355)	(224,197)
Total cost of investments acquired	(11,793,104)	(5,276,481)
Net cash provided by (used in) investing activities	(5,021,150)	20,698,160
Cash flows from financing activities:
Policyholder contract deposits	1,025,008	1,046,208
Policyholder contract withdrawals	(1,158,017)	(978,348)
Payments of principal on notes payable/line of credit	0	(19,000,000)
Purchase of treasury stock	(96,024)	(108,914)
Net cash used in financing activities	(229,033)	(19,041,054)
Net decrease in cash and cash equivalents	(8,505,394)	(358,972)
Cash and cash equivalents at beginning of period	45,263,967	41,185,196
Cash and cash equivalents at end of period	$ 36,758,573	$ 40,826,224